Absolute risk of cardiovascular disease events and blood pressure- and lipid-lowering therapy in Australia

• 1 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT
• 2 Sax Institute, Sydney, NSW
• 3 National Heart Foundation of Australia, Melbourne, VIC

---

• 1. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. Canberra: NVDPA, 2012. https://www.heartfoundation.org.au/images/uploads/publications/Absolute-CVD-Risk-Full-Guidelines.pdf (accessed Nov 2016).
• 2. Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular disease events and blood pressure- and lipid-lowering therapy in Australia. Med J Aust 2016; 204: 320. <MJA full text>
• 3. Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ 2013; 347: f5680.
• 4. Cholesterol Treatment Trialists’ Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.